Tavotek Biotherapeutics rakes in $35m Series B

Tavotek Biotherapeutics, a biotech company, has raised $35 million in Series B financing.

Tavotek Biotherapeutics, a biotech company, has raised $35 million in Series B financing. CS Capital led the round with participation from Fontus Capital.

Source: Press Release